Jin Medical International Ltd.
Company & revenue
About Jin Medical International Ltd.
Who they are
Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement. Their product range additionally features oxygen concentrators and specialized bathing devices. Established in 2006, the company is headquartered in Changzhou, China, and operates as a subsidiary of Jolly Harmony Enterprises Limited.
Detailed revenue, brand and relationship research has not yet been completed for ZJYL.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
55
Fair
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
53
Fair
Financial Strength
37
Business Quality / Moat
62
Management
71
Growth Quality
40
Risk / Durability
60
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
69
Fully Valued
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
62/100
Building Historical Record
Model Score 62/100 — estimates relative performance potential, distinct from WallStreetScore (company quality).
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
WSS currently rates the company as mixed to moderately strong.
At today’s price, the WSS valuation framework currently reads as moderate rather than unusually attractive.
The model outlook is currently moderate.
- •Asset quality scores strongly
- •Valuation scores attractively
- •Debt service risk
- •Debt / balance-sheet profile needs attention
Company-specific research
Questions worth answering for ZJYL
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can ZJYL maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •How long can ZJYL fund negative free cash flow using its current cash position before it may need more debt or new shares?
- •Is ZJYL's debt load manageable relative to cash generation, interest costs and upcoming maturities?
- •Is ZJYL's valuation discount tied to a temporary concern or to a longer-term business risk?
- •What does the current fundamental change risk warning mean for the reliability or interpretation of ZJYL's score?
Essential Investment Snapshot
Wall Street Score
55
Opportunity Score
69
Market Cap
$15.2M
P/E Ratio
5.3
EPS
$0.37
52-Week High
$12.00
52-Week Low
$1.53
Beta
7.33
Intrinsic Value
$5.08
Shares Outstanding
7.8M
Total Revenue
$42.6M
Total Debt
$20.6M
Dividend
No current dividend
Liquidation Value / Share
$3.85
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Weakening momentum
Elevated movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for ZJYL
Detected from reported data — verify before acting.Debt service risk
Interest coverage is low (~1.5x). Earnings may be strained to cover interest expense.
Community Sentiment
0 active · 0 total callsNo personal call yet on ZJYL.
What the Bulls Say
- +Product opportunity: Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement. Their product range additionally features oxygen concentrators and specialized bathing devices. Established in 2006, the company is headquartered in Changzhou, China, and operates as a subsidiary of Jolly Harmony Enterprises Limited.
What the Bears Say
- −Negative free cash flow may increase the need for outside financing and dilution.
Bull and bear cases summarize disclosed catalysts, growth opportunities and risks; they are not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
2 historical score records availablePrevious Score
50
Jul 24, 2026
Change
+5.2
points
Current Score
55
Oct 1, 2026
Category Changes
ZJYL increased 5.2 points because Valuation improved by 77.5 points, Buffett improved by 6.4 points.
Positive Contributors
- + Valuation improved by 77.5 points
- + Buffett improved by 6.4 points
Negative Contributors
- − Management declined by 6.9 points
Projected Score
Projected Score
51
Projected Change
-4.2%
Preliminary comparable-period financial changes suggest decline of approximately 4.2 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
UndervaluedCurrent Price
$1.94
Intrinsic Value
$5.08
Difference
−$3.14
-61.8% vs IV
Margin of Safety
61.8%
Related Companies
Medical - Instruments & SuppliesNews
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial